C HAPTER 01: D RUG D EFINITIONS ,
S TANDARDS , AND I NFORMATION S OURCES
Willihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
MULTIPLE CHOICE
1. Which classification does meperidine (Demerol) fall under?
a. I
b. II
c. III
d. IV
ANS: B
Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse
and may lead to severe psychological and physical dependence. Schedule I
drugs have high potential for abuse and no recognized medical use. Schedule
III drugs have some potential for abuse. Use may lead to low to moderate
physical dependence or high psychological dependence. Schedule IV drugs
have low potential for abuse. Use may lead to limited physical or
ps ychological dependence.
DIF: Cognitive Level: Knowledge REF: p. 10 OBJ: 2
NAT: NCLEX Client Needs Category: Safe, Effective Care
Environment
TOP: Nursing Process Step: Assessment CON: Patient Education |
Addiction | Pain
, 2. Which action would the FDA take to expedite drug development and
approval for an outbreak of smallpox?
a. List smallpox as a health orphan disease.
b. Omit the preclinical research phase.
c. Extend the clinical research phase.
d. Fast track the investigational drug.
ANS: D
Once the Investigational New Drug Application has been approved, the drug
can receive highest priorit y within the agency, which is called fast tracking.
A smallpox outbreak would become a priorit y concern in the world. Orphan
diseases are n ot researched in a priorit y manner. Preclinical research is not
omitted. Extending any phase of the research would mean a longer time to
develop a vaccine. The FDA must ensure that all phases of the preclinical and
clinical research phase have been complet ed in a safe manner.
DIF: Cognitive Level: Knowledge REF: p. 7 OBJ: 5
NAT: NCLEX Client Needs Category: Safe, Effective Care
Environment
TOP: Nursing Process Step: Assessment
CON: Health Care Law | Health Care Policy | Infection | Care
Coordination
3. Which name identifies a drug listed by the US Food and Drug
Administration (FDA)?
a. Brand
b. Non-proprietary
c. Official
d. Trademark
ANS: C
S TANDARDS , AND I NFORMATION S OURCES
Willihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
MULTIPLE CHOICE
1. Which classification does meperidine (Demerol) fall under?
a. I
b. II
c. III
d. IV
ANS: B
Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse
and may lead to severe psychological and physical dependence. Schedule I
drugs have high potential for abuse and no recognized medical use. Schedule
III drugs have some potential for abuse. Use may lead to low to moderate
physical dependence or high psychological dependence. Schedule IV drugs
have low potential for abuse. Use may lead to limited physical or
ps ychological dependence.
DIF: Cognitive Level: Knowledge REF: p. 10 OBJ: 2
NAT: NCLEX Client Needs Category: Safe, Effective Care
Environment
TOP: Nursing Process Step: Assessment CON: Patient Education |
Addiction | Pain
, 2. Which action would the FDA take to expedite drug development and
approval for an outbreak of smallpox?
a. List smallpox as a health orphan disease.
b. Omit the preclinical research phase.
c. Extend the clinical research phase.
d. Fast track the investigational drug.
ANS: D
Once the Investigational New Drug Application has been approved, the drug
can receive highest priorit y within the agency, which is called fast tracking.
A smallpox outbreak would become a priorit y concern in the world. Orphan
diseases are n ot researched in a priorit y manner. Preclinical research is not
omitted. Extending any phase of the research would mean a longer time to
develop a vaccine. The FDA must ensure that all phases of the preclinical and
clinical research phase have been complet ed in a safe manner.
DIF: Cognitive Level: Knowledge REF: p. 7 OBJ: 5
NAT: NCLEX Client Needs Category: Safe, Effective Care
Environment
TOP: Nursing Process Step: Assessment
CON: Health Care Law | Health Care Policy | Infection | Care
Coordination
3. Which name identifies a drug listed by the US Food and Drug
Administration (FDA)?
a. Brand
b. Non-proprietary
c. Official
d. Trademark
ANS: C
